Has had any major surgery, chemotherapy, hormone therapy, investigational agent, or radiotherapy within the last 28 days

Prior treatment with pazopanib, or oxaliplatin.

Known contraindications to the use of oxaliplatin, capecitabine, 5-fluorouracil, or folinic acid.

Participation in any investigational study within 28 days prior to study treatment.

Women who are pregnant or lactating.

Poorly controlled hypertension.

A history of cardiovascular disease, arrhythmias, or significant ECG abnormalities.

Any history of stroke.

Current use of therapeutic warfarin.

Known brain metastases.

History of disease significantly affecting gastrointestinal function or major resection of the stomach or small bowel.

Active infections or other serious illness.

History of allergy to platinum compounds or heparin.

Poor venous access.

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)